World Equity Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$280K Buy
+1,877
New +$263K 0.12% 186
2024
Q2
– Sell
-3,268
Closed -$239K – 291
2024
Q1
$239K Sell
3,268
-376
-10% -$28.9K 0.05% 269
2023
Q4
$295K Sell
3,644
-1,394
-28% -$108K 0.06% 254
2023
Q3
$378K Buy
+5,038
New +$388K 0.08% 235
2023
Q2
– Sell
-90,535
Closed -$1.29M – 412
2023
Q1
$1.29M Buy
90,535
+87,083
+2,523% +$7.21M 0.19% 136
2022
Q4
$296K Sell
3,452
-612
-15% -$48.5K 0.07% 253
2022
Q3
$251K Buy
4,064
+607
+18% +$38.3K 0.06% 271
2022
Q2
$214K Sell
3,457
-113
-3% -$7K 0.05% 308
2022
Q1
$212K Buy
+3,570
New +$228K 0.05% 330

Other funds holding GILD

World Equity Group's GILD Position: Q3 2026 in Review

World Equity Group opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,877 shares worth $280K. The stake represents 0.12% of the portfolio and ranks #186 among its holdings. This is a return to the name: World Equity Group previously reported a position in GILD as recently as Q1 2024.

World Equity Group first reported a position in GILD in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.29M in Q1 2023. 316 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • World Equity Group held 1,877 shares of Gilead Sciences worth $280K as of Q3 2026.
  • Gilead Sciences was a new World Equity Group position in Q3 2026.
  • Gilead Sciences made up 0.12% of World Equity Group's portfolio in Q3 2026, its #186 holding.
  • World Equity Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 9 quarters since.
  • World Equity Group's Gilead Sciences position peaked at $1.29M in Q1 2023.
  • 316 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on World Equity Group's 13F filing for Q3 2026, filed 14 Oct 2026.